Evaluating Simvastatin's Potential Role in Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Alzheimer Disease
Interventions
DRUG

Simvastatin

40 mg tablet each night for one month, then 80 mg for 8 months

DRUG

Placebo

Matching tablet each night for 9 months

Trial Locations (1)

53705

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Paul Beeson Faculty Scholars Program

OTHER

collaborator

The John A. Hartford Foundation

OTHER

collaborator

The Atlantic Philanthropies

OTHER

collaborator

Starr Foundation

OTHER

collaborator

American Federation for Aging Research

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Wisconsin, Madison

OTHER

NCT00486044 - Evaluating Simvastatin's Potential Role in Therapy | Biotech Hunter | Biotech Hunter